Personalis Inc.

4.77-0.5500-10.34%Vol 359.77K1Y Perf -70.08%
Aug 16th, 2022 16:00 DELAYED
BID4.66 ASK5.22
Open5.27 Previous Close5.32
Pre-Market- After-Market4.82
 - -  0.05 1.05%
Target Price
18.20 
Analyst Rating
Moderate Buy 1.80
Potential %
281.55 
Finscreener Ranking
★★★★ —    52.39
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★     51.47
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★     51.40
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
8.24 
Earnings Rating
Market Cap219.03M 
Earnings Date
3rd Aug 2022
Alpha-0.05 Standard Deviation0.20
Beta1.67 

Today's Price Range

4.770.00

52W Range

3.1323.04

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Week
0.00%
1 Month
17.78%
3 Months
-0.83%
6 Months
-53.10%
1 Year
-70.08%
3 Years
-73.57%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
PSNL4.77-0.5500-10.34
AAPL173.03-0.1600-0.09
GOOG122.51-0.3700-0.30
MSFT292.71-0.7600-0.26
XOM91.46-0.8600-0.93
WFC46.060.31000.68
JNJ167.571.48000.89
FB196.640.99000.51
GE81.071.26001.58
JPM123.631.17000.96
 
ProfitabilityValueIndustryS&P 500US Markets
32.20
-122.20
-113.40
-98.50
-81.53
RevenueValueIndustryS&P 500US Markets
76.41M
1.66
17.15
-
Earnings HistoryEstimateReportedSurprise %
Q02 2022-0.63-0.604.76
Q01 2022-0.57-0.63-10.53
Q04 2021-0.51-0.4511.76
Q03 2021-0.40-0.400.00
Q02 2021-0.39-0.3412.82
Q01 2021-0.37-0.2921.62
Q04 2020-0.30-0.34-13.33
Q03 2020-0.30-0.2710.00
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-0.63
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume359.77K
Shares Outstanding45.92K
Shares Float27.37M
Trades Count3.64K
Dollar Volume1.76M
Avg. Volume658.19K
Avg. Weekly Volume739.80K
Avg. Monthly Volume587.27K
Avg. Quarterly Volume647.50K

Personalis Inc. (NASDAQ: PSNL) stock closed at 4.77 per share at the end of the most recent trading day (a -10.34% change compared to the prior day closing price) with a volume of 359.77K shares and market capitalization of 219.03M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 235 people. Personalis Inc. CEO is John West.

The one-year performance of Personalis Inc. stock is -70.08%, while year-to-date (YTD) performance is -66.57%. PSNL stock has a five-year performance of %. Its 52-week range is between 3.13 and 23.04, which gives PSNL stock a 52-week price range ratio of 8.24%

Personalis Inc. currently has a PE ratio of -2.60, a price-to-book (PB) ratio of 0.93, a price-to-sale (PS) ratio of 3.20, a price to cashflow ratio of 103.80, a PEG ratio of 2.32, a ROA of -25.26%, a ROC of -27.70% and a ROE of -31.03%. The company’s profit margin is -81.53%, its EBITDA margin is -113.40%, and its revenue ttm is $76.41 Million , which makes it $1.66 revenue per share.

Of the last four earnings reports from Personalis Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.63 for the next earnings report. Personalis Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Personalis Inc. is Moderate Buy (1.8), with a target price of $18.2, which is +281.55% compared to the current price. The earnings rating for Personalis Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Personalis Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Personalis Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 25.97, ATR14 : 0.50, CCI20 : 167.41, Chaikin Money Flow : 0.17, MACD : 0.29, Money Flow Index : 69.55, ROC : 40.37, RSI : 49.72, STOCH (14,3) : 87.59, STOCH RSI : 0.96, UO : 60.66, Williams %R : -12.41), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Personalis Inc. in the last 12-months were: Aaron L. Tachibana (Sold 36 172 shares of value $358 848 ), John West (Option Excercise at a value of $201 463), John West (Sold 269 557 shares of value $3 106 078 ), Richard Chen (Sold 15 259 shares of value $104 186 ), Stephen M. Moore (Sold 8 229 shares of value $40 866 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (60.00 %)
4 (66.67 %)
4 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (40.00 %)
2 (33.33 %)
2 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.80
Moderate Buy
1.67
Moderate Buy
1.67

Personalis Inc.

Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services.

CEO: John West

Telephone: +1 650 752-1300

Address: 1330 O'Brien Drive, Menlo Park 94025, CA, US

Number of employees: 235

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

54%46%

Bearish Bullish

55%45%

TipRanks News for PSNL

Fri, 06 May 2022 16:31 GMT Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Personalis (PSNL) and NuVasive (NUVA)

- TipRanks. All rights reserved.

Fri, 07 Jan 2022 11:35 GMT Personalis (PSNL) Receives a Hold from Needham

- TipRanks. All rights reserved.

News

Stocktwits